(Q35749310)

10 August 2017

title

Use of ceftazidime in the therapy of serious infections, including those due to multiresistant organisms (English)

1 reference

https://api.crossref.org/works/10.1128/AAC.24.2.176

10 August 2017

main subject

multiple drug resistance

1 reference

1 reference

1 reference

6 October 2023

author name string

N. Clumeck

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6357068

6 October 2023

Y. Van Laethem

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6357068

6 October 2023

B. Gordts

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6357068

6 October 2023

N. Jaspar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6357068

6 October 2023

J. P. Butzler

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6357068

6 October 2023

language of work or name

English

0 references

publication date

1 August 1983

1 reference

10 August 2017

number of pages

5

1 reference

full work available at URL

inferred from page(s)

https://europepmc.org/articles/pmc185133?pdf=render

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6357068

https://europepmc.org/articles/PMC185133

6 October 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6357068

https://europepmc.org/articles/PMC185133?pdf=render

6 October 2023

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6357068

https://journals.asm.org/doi/pdf/10.1128/AAC.24.2.176

6 October 2023

1 reference

https://api.crossref.org/works/10.1128/AAC.24.2.176

Antimicrobial Agents and Chemotherapy

6 October 2023

published in

1 reference

10 August 2017

volume

24

1 reference

10 August 2017

issue

2

1 reference

10 August 2017

page(s)

176-180

1 reference

GR 20263, a new broad-spectrum cephalosporin with anti-pseudomonal activity

10 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185133

GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and Enterobacteriaceae

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185133

The new beta-lactamase-stable cephalosporins

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185133

Comparative antipseudomonal activity of some newer beta-lactam agents

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185133

Comparison of in vitro activity of GR 20263, a novel cephalosporin derivative, with activities of other beta-lactam compounds

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185133

Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185133

Clinical evaluation of cefotaxime for therapy of lower respiratory tract infections

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185133

Cefotaxime Therapy of Serious Infections with Multiresistant Gram-Negative Bacilli

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185133

Comparative Multiple-Dose Pharmacokinetics of Cefotaxime, Moxalactam, and Ceftazidime

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185133

Clinical evaluation of moxalactam

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185133

Ceftazidime--a new extended-spectrum cephalosporin

12 July 2018

1 reference

12 December 2020

Ceftazidime in cystic fibrosis

1 reference

12 December 2020

Clinical evaluation of moxalactam therapy

1 reference

12 December 2020

Moxalactam therapy for bacterial infections

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.24.2.176

1 reference

10 August 2017

1 reference

10 August 2017

1 reference